U.S. flag

An official website of the United States government

NM_001184880.2(PCDH19):c.1639G>C (p.Ala547Pro) AND Developmental and epileptic encephalopathy, 9

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Dec 2, 2022
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001218626.10

Allele description [Variation Report for NM_001184880.2(PCDH19):c.1639G>C (p.Ala547Pro)]

NM_001184880.2(PCDH19):c.1639G>C (p.Ala547Pro)

Gene:
PCDH19:protocadherin 19 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.1
Genomic location:
Preferred name:
NM_001184880.2(PCDH19):c.1639G>C (p.Ala547Pro)
HGVS:
  • NC_000023.11:g.100406959C>G
  • NG_021319.1:g.8315G>C
  • NM_001105243.2:c.1639G>C
  • NM_001184880.2:c.1639G>CMANE SELECT
  • NM_020766.3:c.1639G>C
  • NP_001098713.1:p.Ala547Pro
  • NP_001171809.1:p.Ala547Pro
  • NP_065817.2:p.Ala547Pro
  • LRG_843t1:c.1639G>C
  • LRG_843:g.8315G>C
  • LRG_843p1:p.Ala547Pro
  • NC_000023.10:g.99661957C>G
  • NM_001184880.1:c.1639G>C
Protein change:
A547P
Links:
dbSNP: rs1928375454
NCBI 1000 Genomes Browser:
rs1928375454
Molecular consequence:
  • NM_001105243.2:c.1639G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001184880.2:c.1639G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020766.3:c.1639G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Developmental and epileptic encephalopathy, 9 (DEE9)
Synonyms:
EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION; JUBERG-HELLMAN SYNDROME; PCDH19-Related X-Linked Female-Limited Epilepsy with Mental Retardation; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010246; MedGen: C1848137; Orphanet: 2076; OMIM: 300088

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001390514Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Dec 2, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002583535Pediatric Department, Peking University First Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jun 1, 2022)
de novoresearch

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyesnot providednot providednot providednot providednot providedresearch
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Neurological Diseases With Autism Spectrum Disorder: Role of ASD Risk Genes.

Xiong J, Chen S, Pang N, Deng X, Yang L, He F, Wu L, Chen C, Yin F, Peng J.

Front Neurosci. 2019;13:349. doi: 10.3389/fnins.2019.00349.

PubMed [citation]
PMID:
31031587
PMCID:
PMC6470315
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001390514.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 947530). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 547 of the PCDH19 protein (p.Ala547Pro).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Pediatric Department, Peking University First Hospital, SCV002583535.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024